Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (19018)
All Articles published online
|
Publishing Process of This Article
|
Nov 15, 2015 (publication date) through Apr 1, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Akiho H, Yokoyama A, Abe S, Nakazono Y, Murakami M, Otsuka Y, Fukawa K, Esaki M, Niina Y, Ogino H. Promising biological therapies for ulcerative colitis: A review of the literature. World J Gastrointest Pathophysiol 2015; 6(4): 219-227 [PMID: 26600980 DOI: 10.4291/wjgp.v6.i4.219] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Akiho H, Yokoyama A, Abe S, Nakazono Y, Murakami M, Otsuka Y, Fukawa K, Esaki M, Niina Y, Ogino H. Promising biological therapies for ulcerative colitis: A review of the literature. World J Gastrointest Pathophysiol 2015; 6(4): 219-227 [PMID: 26600980 DOI: 10.4291/wjgp.v6.i4.219] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v6/i4/219.htm |
| Number | Citing Articles |
| 1 |
Muhammed Babakir-Mina. Epidemiological and Clinical Aspects of Ulcerative Colitis in Mosul city, Iraq. Kurdistan Journal of Applied Research 2019; : 56 doi: 10.24017/science.2019.ICHMS.6
|
| 2 |
Valentina Andretto, Silvia Dusi, Serena Zilio, Mathieu Repellin, David Kryza, Stefano Ugel, Giovanna Lollo. Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines. Advanced Drug Delivery Reviews 2023; 201: 115080 doi: 10.1016/j.addr.2023.115080
|
| 3 |
Keiichi Tominaga, Mimari Kanazawa, Takanao Tanaka, Shunsuke Kojimahara, Takeshi Sugaya, Shoko Watanabe, Akira Yamamiya, Yuichi Majima, Makoto Iijima, Kenichi Goda, Atsushi Irisawa. A Case of Lung Abscess Caused by Double Immunosuppressive Therapy to Treat Ulcerative Colitis. Medicina 2020; 56(11): 595 doi: 10.3390/medicina56110595
|
| 4 |
Charlie W. Lees, Joana Torres, Yvette Leung, Séverine Vermeire, Marc Fellmann, Irene Modesto, Aoibhinn McDonnell, Krisztina Lazin, Michael Keating, Martina Goetsch, Joseph Wu, Edward V. Loftus. Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: an analysis of the phase II OASIS and phase III ELEVATE UC 52 and ELEVATE UC 12 clinical trials. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241293643
|
| 5 |
Runbin Sun, Dandan Jin, Fei Fei, Zhi Xu, Bei Cao, Juan Li. Mushroom polysaccharides from Grifola frondosa (Dicks.) Gray and Inonotus obliquus (Fr.) Pilat ameliorated dextran sulfate sodium-induced colitis in mice by global modulation of systemic metabolism and the gut microbiota. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1172963
|
| 6 |
Fatemeh Vazirian, Sara Samadi, Mohammadreza Abbaspour, Amirmahdi Taleb, Hadi Bagherhosseini, Hooman Mosannen Mozaffari, Amir Hooshang Mohammadpour, Seyed Ahmad Emami. Evaluation of the efficacy of Thymus kotschyanus extract as an additive treatment in patients with ulcerative colitis: a randomized double-blind placebo-controlled trial. Inflammopharmacology 2022; 30(6): 2145 doi: 10.1007/s10787-022-00991-3
|
| 7 |
Janakiraman Pillai Udaiyappan, Rengasamy Balakrishnan, Manivasagam Muthukumaran Tamilarasan, Balamuralikrishnan Balasubramanian, Kasim Sakran Abass. Selective Inhibition of Tumor Necrosis Factor for Attenuating Alzheimer’s Disease: Strategies Targeting Neuroinflammation. Inflammation 2026; 49(1) doi: 10.1007/s10753-026-02492-9
|
| 8 |
Anqi Fan, Bao-Long Hou, Zhishu Tang, Ting Wang, Dongbo Zhang, Yanni Liang, Zheng Wang. Liquid Chromatography-Tandem Mass Spectrometry-Based Metabolomics Analysis of Indigo Naturalis Treatment of Ulcerative Colitis in Mice. Journal of Medicinal Food 2023; 26(12): 877 doi: 10.1089/jmf.2023.K.0132
|
| 9 |
Leon D. Averbukh, George Y. Wu. Role of Biologics in the Development of Autoimmune Hepatitis: A Review. Journal of Clinical and Translational Hepatology 2018; 6(4): 1 doi: 10.14218/JCTH.2018.00039
|
| 10 |
Qin Zhu, Peifen Zheng, Jianying Zhou, Xinyu Chen, Yuliang Feng, Weifeng Wang, Feng Zhou, Qiaona He. Andrographolide affects Th1/Th2/Th17 responses of peripheral blood mononuclear cells from ulcerative colitis patients. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8992
|
| 11 |
Domenico Corica, Claudio Romano. Biological Therapy in Pediatric Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2017; 51(2): 100 doi: 10.1097/MCG.0000000000000696
|
| 12 |
Zhenzhen Jin, Xiangjing Cao, Qinglong Guo, Cong Zhang, Qingrong Li, Wenqi Wang, Yong Lv, Yan Ma, Xianwen Wang. TA-V Nanozymes with Acid Resistance Capabilities Effectively Target and Alleviate Ulcerative Colitis Lesions via Oral Delivery. ACS Applied Materials & Interfaces 2025; 17(10): 14912 doi: 10.1021/acsami.4c20322
|
| 13 |
Yiyoung Kwon, Eun Sil Kim, Yon Ho Choe, Mi Jin Kim. How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study. World Journal of Gastroenterology 2022; 28(28): 3666-3681 doi: 10.3748/wjg.v28.i28.3666
|
| 14 |
Marisa Iborra, Belén Beltrán, Nuria Maroto, Pablo Navarro-Cortés, Maia Boscá-Watts, Isabel Ferrer-Bradley, Natalia García-Morales, Esteban Sáez-González, Joaquín Hinojosa, Miguel Mínguez, Pilar Nos. Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents. Gastroenterología y Hepatología (English Edition) 2018; 41(9): 535 doi: 10.1016/j.gastre.2018.11.007
|
| 15 |
Tomoko Sairenji, Kimberly L. Collins, David V. Evans. An Update on Inflammatory Bowel Disease. Primary Care: Clinics in Office Practice 2017; 44(4): 673 doi: 10.1016/j.pop.2017.07.010
|
| 16 |
Marisa Iborra, Belén Beltrán, Nuria Maroto, Pablo Navarro-Cortés, Maia Boscá-Watts, Isabel Ferrer-Bradley, Natalia García-Morales, Esteban Sáez-González, Joaquín Hinojosa, Miguel Mínguez, Pilar Nos. Vedolizumab, una opción en pacientes con enfermedad inflamatoria intestinal intolerantes a tiopurinas y refractarios a biológicos. Gastroenterología y Hepatología 2018; 41(9): 535 doi: 10.1016/j.gastrohep.2018.06.001
|
| 17 |
Mingyo Kim, Yong-ho Choe, Sang-il Lee. Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research. Immune Network 2022; 22(1) doi: 10.4110/in.2022.22.e8
|
| 18 |
Xian-Qun Chu, Jing Wang, Guang-Xiang Chen, Guan-Qi Zhang, De-Yong Zhang, Yong-Yan Cai. Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK/STAT3 signaling pathway in a mouse model of ulcerative colitis. Pathology - Research and Practice 2018; 214(1): 151 doi: 10.1016/j.prp.2017.10.003
|
| 19 |
Luiz Henrique Agra Cavalcante-Silva, José Marreiro de Sales-Neto, Mariana Mendonça Soares, Davi Azevedo Ferreira, Anna Beatriz Araujo Medeiros, Sandra Rodrigues-Mascarenhas. Cardiotonic Steroids as a Potential Novel Approach for Immunomodulation in Inflammatory Bowel Disease. Journal of Clinical Medicine 2025; 14(12): 4132 doi: 10.3390/jcm14124132
|
| 20 |
Yunliang Wang, Lijuan Liu, Yi Guo, Tangyou Mao, Rui Shi, Junxiang Li. Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis. Experimental and Therapeutic Medicine 2017; 14(2): 1327 doi: 10.3892/etm.2017.4701
|
| 21 |
Titilayo Omolara Johnson, Kenneth Daniel Odoh, Charles Obiora Nwonuma, Augustina Oduje Akinsanmi, Abayomi Emmanuel Adegboyega. Biochemical evaluation and molecular docking assessment of the anti-inflammatory potential of Phyllanthus nivosus leaf against ulcerative colitis. Heliyon 2020; 6(5): e03893 doi: 10.1016/j.heliyon.2020.e03893
|
| 22 |
Haifa Eldew, Jonathan Soldera. Evaluation of biological therapies in autoimmune hepatitis: A case-based systematic review. World Journal of Gastrointestinal Pathophysiology 2025; 16(1): 101481 doi: 10.4291/wjgp.v16.i1.101481
|
| 23 |
Akram Sarabi Asiabar, Hamid Asadzade Aghdaei, Azar Sabokbar, Mohammad Reza Zali, Mohammad Mehdi Feizabadi. Prevalence of Adherent-Invasive Escherichia coli with fimH Gene Isolated from Iranian Patients with Ulcerative Colitis. Jundishapur Journal of Microbiology 2017; 10(7) doi: 10.5812/jjm.13858
|
| 24 |
Yan-Meng Lu, Jiao-Jiao Xie, Cong-Gao Peng, Bao-Hong Wang, Kai-Cen Wang, Lan-Juan Li. Enhancing Clinical Efficacy through the Gut Microbiota: A New Field of Traditional Chinese Medicine. Engineering 2019; 5(1): 40 doi: 10.1016/j.eng.2018.11.013
|
| 25 |
Yasuo Suzuki, Mamoru Watanabe, Toshiyuki Matsui, Satoshi Motoya, Tadakazu Hisamatsu, Hirotoshi Yuasa, Junichi Tabira, Naoki Isogawa, Shinichi Tsuchiwata, Shoko Arai, Toshifumi Hibi. Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis. Inflammatory Intestinal Diseases 2019; 4(4): 131 doi: 10.1159/000502144
|
| 26 |
Chhabi Lal Chaudhary, Prakash Chaudhary, Sadan Dahal, Dawon Bae, Tae-gyu Nam, Jung-Ae Kim, Byeong-Seon Jeong. Inhibition of colitis by ring-modified analogues of 6-acetamido-2,4,5-trimethylpyridin-3-ol. Bioorganic Chemistry 2020; 103: 104130 doi: 10.1016/j.bioorg.2020.104130
|
| 27 |
Nitin Sharma, Anjana Sharma, Aseem Bhatnagar, Dhruv Nishad, Ritu Karwasra, Kushagra Khanna, Deeksha Sharma, Neeraj Kumar, Gaurav Kumar Jain. Novel gum acacia based macroparticles for colon delivery of Mesalazine: Development and gammascintigraphy study. Journal of Drug Delivery Science and Technology 2019; 54: 101224 doi: 10.1016/j.jddst.2019.101224
|
| 28 |
Ye Jin Yang, Min Jung Kim, Ji Woong Heo, Han Nim Choi, Dongbin Lee, Young Hun Kim, Kwang Il Park. Angelica gigas Nakai hot water extracts alleviate IL-6-induced ulcerative colitis by restoring intestinal barrier function. Molecular & Cellular Toxicology 2025; 21(3): 639 doi: 10.1007/s13273-025-00531-4
|
| 29 |
Sa-Rang Oh, Seon Ok, Tae-Sung Jung, Sang-Ok Jeon, Ji-Min Park, Ji-wook Jung, Deok-Seon Ryu. Protective effect of decursin and decursinol angelate-rich Angelica gigas Nakai extract on dextran sulfate sodium-induced murine ulcerative colitis. Asian Pacific Journal of Tropical Medicine 2017; 10(9): 864 doi: 10.1016/j.apjtm.2017.08.017
|
| 30 |
Surya Sudheer, Prateeksha Gangwar, Zeba Usmani, Minaxi Sharma, Vivek Kumar Sharma, Siva Sankar Sana, Fausto Almeida, Nawal Kishore Dubey, Dhananjaya Pratap Singh, Neeraj Dilbaghi, Hamid Reza Khayat Kashani, Vijai Kumar Gupta, Brahma Nand Singh, Maryam Khayatkashani, Seyed Mohammad Nabavi. Shaping the gut microbiota by bioactive phytochemicals: An emerging approach for the prevention and treatment of human diseases. Biochimie 2022; 193: 38 doi: 10.1016/j.biochi.2021.10.010
|
| 31 |
Foad Rommasi, Mohammad Javad Nasiri, Mehdi Mirsaeidi. Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features. Molecular and Cellular Biochemistry 2022; 477(3): 711 doi: 10.1007/s11010-021-04325-9
|
| 32 |
Yasaman Aliasghari Sakha, Ehsan Ehsani, Elham Roshandel, Arsalan Jalili, Negar Vahdani, Abbas Hajifathali. Assessment of the Effect of Infliximab on Immunomodulation Properties of Mesenchymal Stem Cells in Vitro. Advanced Pharmaceutical Bulletin 2020; 11(4): 739 doi: 10.34172/apb.2021.083
|
| 33 |
Areeg Bala, Mahmoud Barbarawi, Shima Sidahmed, Ashok Kumar Kanugula, Ghassan Bachuwa. A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case Report. Cureus 2020; doi: 10.7759/cureus.9615
|
| 34 |
Victoria Hall, Douglas Johnson, Joseph Torresi. Travel and biologic therapy: travel-related infection risk, vaccine response and recommendations. Journal of Travel Medicine 2018; 25(1) doi: 10.1093/jtm/tay018
|
| 35 |
Lixu Zhu, Lei Qiao, Xina Dou, Xiaofan Song, Jiajing Chang, Xiaonan Zeng, Chunlan Xu. Lactobacillus casei ATCC 393 combined with vasoactive intestinal peptide alleviates dextran sodium sulfate-induced ulcerative colitis in C57BL/6 mice via NF-κB and Nrf2 signaling pathways. Biomedicine & Pharmacotherapy 2023; 165: 115033 doi: 10.1016/j.biopha.2023.115033
|
| 36 |
Yumeng Shen, Junfeng Zou, Mengjun Chen, Zhimiao Zhang, Chen Liu, Shu Jiang, Dawei Qian, Jin-Ao Duan. Protective effects of Lizhong decoction on ulcerative colitis in mice by suppressing inflammation and ameliorating gut barrier. Journal of Ethnopharmacology 2020; 259: 112919 doi: 10.1016/j.jep.2020.112919
|
| 37 |
Stefka Stoilova, Daniela Taneva, Mariela Geneva-Popova. Treatment with biologics of patients with inflammatory joint diseases. Pharmacia 2024; 71: 1 doi: 10.3897/pharmacia.71.e132252
|
| 38 |
HaiJing Zhang, GuangMing Song, ZhiHui Zhang, HuaChen Song, XiaoNan Tang, AnJun Deng, WenJie Wang, LianQiu Wu, HaiLin Qin. Colitis Is Effectively Ameliorated by (±)-8-Acetonyl-dihydrocoptisine via the XBP1-NF-κB Pathway. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00619
|
| 39 |
Renren Bai, Xiaokang Jie, Chuansheng Yao, Yuanyuan Xie. Discovery of small-molecule candidates against inflammatory bowel disease. European Journal of Medicinal Chemistry 2020; 185: 111805 doi: 10.1016/j.ejmech.2019.111805
|
| 40 |
Mohammad Irshad Reza, Nilesh S. Ambhore. Inflammation in Asthma: Mechanistic Insights and the Role of Biologics in Therapeutic Frontiers. Biomedicines 2025; 13(6): 1342 doi: 10.3390/biomedicines13061342
|
| 41 |
Ashvini Chopade, Ranjit Ingole, Varad Anandgaonkar, Bhupesh Kamdi, Pramod Ingle, Aniket Gade, Sunil Hajare, Sunil Waghmare. Dalbergia sissoo - Derived Silver Nanoparticles: A Therapeutic Shield against Experimentally induced Ulcerative Colitis in Murine Models. Progress in Nanoscience and Nanotechnology 2026; 16(1) doi: 10.2174/0122106812413004251024064906
|
| 42 |
Philip Minar, Dana MH. Dykes, Ana Catalina Arce-Clachar, Shehzad A. Saeed. Pediatric Inflammatory Bowel Disease. 2017; : 389 doi: 10.1007/978-3-319-49215-5_32
|
| 43 |
Baisong Zhou, Juntong Liu, Yaru Wang, Fulin Wu, Caixia Wang, Cuizhu Wang, Jinping Liu, Pingya Li. Protective Effect of Ethyl Rosmarinate against Ulcerative Colitis in Mice Based on Untargeted Metabolomics. International Journal of Molecular Sciences 2022; 23(3): 1256 doi: 10.3390/ijms23031256
|
| 44 |
Tzu-Chen Lo, Yu-Yen Chen, Hsin-Hua Chen. Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study. Eye 2022; 36(6): 1288 doi: 10.1038/s41433-021-01645-4
|
| 45 |
Ruben J. Colman, Dana M. H. Dykes, Ana Catalina Arce-Clachar, Shehzad A. Saeed, Phillip Minar. Pediatric Inflammatory Bowel Disease. 2023; : 407 doi: 10.1007/978-3-031-14744-9_31
|
| 46 |
Rajeshwar Nath Srivastava, Shatakshi Pant, Sudeepti Ratan Srivastava, Amar Chandra Sharma, Saloni Raj. Ankylosing Spondylitis - Recent Concepts. 2023; doi: 10.5772/intechopen.108698
|
| 47 |
Shubhasree Banerjee, Ann Biehl, Massimo Gadina, Sarfaraz Hasni, Daniella M. Schwartz. JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects. Drugs 2017; 77(5): 521 doi: 10.1007/s40265-017-0701-9
|
| 48 |
Jianlong Lao, Shuping Yan, Yanhong Yong, Yin Li, Zhaohai Wen, Xiaoyong Zhang, Xianghong Ju, Youquan Li. Lacticaseibacillus casei IB1 Alleviates DSS-Induced Inflammatory Bowel Disease by Regulating the Microbiota and Restoring the Intestinal Epithelial Barrier. Microorganisms 2024; 12(7): 1379 doi: 10.3390/microorganisms12071379
|
| 49 |
Pooja Kushwaha, Rahila Qureshi, Nooruddin Khan, Sangita Mukhopadhyay. Revolutionizing IBD therapy: Insights into contemporary treatment strategies. International Reviews of Immunology 2026; 45(1): 1 doi: 10.1080/08830185.2025.2563522
|